Table 3 Baseline characteristics of colorectal cancer with CVD and colorectal cancer without CVD before and after PSM in the overall survival analysis
From: Impact of colour vision deficiency on bladder and colorectal cancer survival
Baseline characteristics | Before PSM | After PSM | ||||
|---|---|---|---|---|---|---|
Colorectal cancer with CVD (n = 216) | Colorectal cancer control (n = 757,629) | P value | Colorectal cancer with CVD (n = 187) | Colorectal cancer control (n = 187) | P value | |
Current age, years (mean ± s.d.) | 72.2 ± 15.3 | 71.3 ± 14.8 | 0.42 | 72.3 ± 15.2 | 72.9 ± 14.0 | 0.69 |
Age at index | 65.0 ± 15.1 | 64.6 ± 14.8 | 0.72 | 65.2 ± 15.0 | 66.7 ± 14.9 | 0.31 |
Age at index below 45 years (%) | 11.7% | 8.8% | 0.16 | 11.2% | 11.2% | 1.0 |
Age at index 45–59 years (%) | 17.6% | 24.8% | 0.02 | 17.6% | 16.0% | 0.68 |
Age at index 60–74 years (%) | 37.8% | 39.3% | 0.67 | 38.0% | 39.0% | 0.83 |
Age at index at least 75 years (%) | 33.0% | 27.2% | 0.07 | 33.2% | 33.7% | 0.91 |
Sex (%) | ||||||
Female | 29.8% | 46.3% | <0.0001 | 29.9% | 29.9% | 1.0 |
Male | 66.0% | 51.3% | <0.0001 | 66.3% | 66.8% | 0.91 |
Race (%) | ||||||
White | 74.5% | 45.8% | <0.0001 | 74.3% | 76.5% | 0.63 |
Black or African American | 8.0% | 7.0% | 0.58 | 8.0% | 5.9% | 0.42 |
Asian | 5.3% | 5.8% | 0.77 | 5.3% | 5.3% | 1.0 |
Hispanic/Latino | 5.3% | 3.3% | 0.11 | 5.3% | 5.3% | 1.0 |
Unknown | 10.6% | 37.1% | <0.0001 | 10.7% | 9.6% | 0.73 |
Cancer diagnoses (%) | ||||||
ICD-10 colon cancer (C18) | 73.9% | 63.7% | 0.004 | 73.8% | 71.7% | 0.64 |
ICD-10 rectosigmoid junction cancer (C19) | 9.0% | 6.3% | 0.12 | 9.1% | 8.0% | 0.71 |
ICD-10 rectum cancer (C20) | 20.2% | 22.6% | 0.43 | 20.3% | 23.0% | 0.53 |
ICD-O colon cancer (C18) | 5.3% | 12.8% | 0.002 | 5.3% | 5.3% | 1.0 |
ICD-O rectosigmoid junction cancer (C19) | 5.3% | 0.6% | <0.0001 | 5.3% | 5.3% | 1.0 |
ICD-O rectum cancer (C20) | 5.3% | 2.8% | 0.04 | 5.3% | 5.3% | 1.0 |
Systemic associations (%) | ||||||
Hypertension | 60.1% | 29.3% | <0.0001 | 59.9% | 62.0% | 0.67 |
Diabetes mellitus | 26.6% | 13.7% | <0.0001 | 26.7% | 27.3% | 0.91 |
Hyperlipidaemia | 39.9% | 15.9% | <0.0001 | 40.1% | 40.6% | 0.92 |
Disorders of lipoprotein metabolism | 47.3% | 21.3% | <0.0001 | 47.6% | 48.1% | 0.92 |
Nicotine dependence | 19.7% | 6.5% | <0.0001 | 19.3% | 17.1% | 0.59 |
